Vascular calcification is a very common event in patients affected by diabetes and chronic kidney disease (CKD). Recently, it has been well documented that abnormalities in mineral and bone metabolism in CKD patients are associated with increased morbidity and mortality. Elevated serum phosphate and calcium-phosphate product levels play an important role in the pathogenesis of vascular mineralization in uremic patients and also appear to be associated with increased cardiovascular mortality. Together with classical passive precipitation of calciumphosphate in soft tissues, during the last decade it has been demonstrated that inorganic phosphate may cause extraskeletal calcification directly through a real “ossification” of the tunica media in the vasculature of CKD patients. Therefore, control of phosphate retention is now an even more crucial target of treatment in patients affected by chronic kidney disease. (Heart International 2006; 2: 6-11)
Vascular calcification, Phosphate, Chronic kidney disease
Mario Cozzolino, MD, Renal Unit, Ospedale San Paolo, Azienda Ospedale San Paolo, Via A. di Rudinì, 8, 20142 Milano – Italy, firstname.lastname@example.org
Share this Article
Related Content In Arrhythmia
Radiofrequency Lesion Quality Markers: Current State of Knowledge
European Journal of Arrhythmia & Electrophysiology. 2022;8(1):2-6
Radiofrequency (RF) ablation involves delivering medium-to-high-frequency alternating current, which is electrically conducted to cardiac tissue that constitutes a part of the circuit. The unipolar circuitry contains the generator, transmission lines, catheter, cardiac tissue, interposed tissue and dispersive electrode (ground pad/indifferent electrode). Bipolar systems, whereby the RF current flows between two electrodes, either on the same […]
Remote Monitoring of Cardiac Arrhythmias Using Wearable Digital Technology: Paradigm Shift or Pipe Dream?
European Journal of Arrhythmia & Electrophysiology. 2022;8(1):7-12
Several smart, connected and direct-to-consumer wearable devices capable of detecting cardiac arrhythmias have proliferated in the marketplace in the last decade. Increasingly, these devices are being marketed as “medical grade” in addition to “wellness” devices.1 New iterations of smartwatch and smartphone technology incorporate biosensors and advanced artificial intelligence (AI) algorithms equipped to diagnose cardiac arrhythmias; examples […]
Foreword – European Journal of Arrhythmia & Electrophysiology. 2021;7(1):1
European Journal of Arrhythmia & Electrophysiology. 2021;7(1):1
Welcome to a new issue of the European Journal of Arrhythmia & Electrophysiology. As the ongoing coronavirus disease 2019 (COVID-19) pandemic continues to provide unprecedented challenges for electrophysiologists and other healthcare providers who manage arrhythmias, we hope you find these topical articles interesting and useful. We begin with an editorial from Professor Hugh Calkins and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!